Revolution Medicines (RVMD) Interest Coverage Ratio (2019 - 2026)

Revolution Medicines' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 0.38 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 73.0% year-over-year to 0.38 in Q1 2026; TTM through Mar 2026 was 1.19, a 74.35% increase from a year earlier, with the FY2025 full-year figure at 1.34, up 46.49% from the prior year.
• Interest Coverage Ratio fell to 0.38 in Q1 2026 per RVMD's latest filing, from 29.5 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 77.01 in Q4 2024 and bottomed at 1.41 in Q1 2025.
• The 5-year median for Interest Coverage Ratio is 0.88 (2022), against an average of 5.88.
• Across the five-year window, Interest Coverage Ratio plunged 208.95% in 2022 and soared 7981.03% in 2024, its largest moves.
• Year by year, Interest Coverage Ratio stood at 0.84 in 2022, then declined by 16.71% to 0.98 in 2023, then jumped by 7981.03% to 77.01 in 2024, then slumped by 61.69% to 29.5 in 2025, then sank by 101.29% to 0.38 in 2026.
• Per Business Quant, the three latest RVMD Interest Coverage Ratio figures stand at 0.38 (Q1 2026), 29.5 (Q4 2025), and 0.96 (Q3 2025).